CN1279612A - 免疫应答的调制 - Google Patents

免疫应答的调制 Download PDF

Info

Publication number
CN1279612A
CN1279612A CN98810397A CN98810397A CN1279612A CN 1279612 A CN1279612 A CN 1279612A CN 98810397 A CN98810397 A CN 98810397A CN 98810397 A CN98810397 A CN 98810397A CN 1279612 A CN1279612 A CN 1279612A
Authority
CN
China
Prior art keywords
chemical compound
animal
disease
alkyl
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN98810397A
Other languages
English (en)
Chinese (zh)
Inventor
C·J·兰多尔
G·J·杜普瑞兹
V·R·施拉克
D·C·阿特费尔德
J·B·范丹伯加尔丹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FRANGOLD HOLDINGS LTS
Original Assignee
FRANGOLD HOLDINGS LTS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FRANGOLD HOLDINGS LTS filed Critical FRANGOLD HOLDINGS LTS
Publication of CN1279612A publication Critical patent/CN1279612A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN98810397A 1997-09-16 1998-09-16 免疫应答的调制 Pending CN1279612A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA97/8319 1997-09-16
ZA978319 1997-09-16

Publications (1)

Publication Number Publication Date
CN1279612A true CN1279612A (zh) 2001-01-10

Family

ID=25586589

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98810397A Pending CN1279612A (zh) 1997-09-16 1998-09-16 免疫应答的调制

Country Status (10)

Country Link
EP (1) EP1019063A4 (fr)
JP (1) JP2001516721A (fr)
CN (1) CN1279612A (fr)
AU (1) AU737867B2 (fr)
BR (1) BR9812321A (fr)
CA (1) CA2304119A1 (fr)
IL (1) IL135091A0 (fr)
NO (1) NO20001341L (fr)
NZ (1) NZ503418A (fr)
WO (1) WO1999013885A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2324631A1 (fr) * 2000-10-26 2002-04-26 Virodene Pharmaceutical Holdings (Proprietary) Limited Substance ou composition pour le traitement du cancer
WO2005053641A1 (fr) * 2003-12-05 2005-06-16 Namibia Medical Investments (Pty) Limited Timbre

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814659A (en) * 1996-04-23 1998-09-29 Dtr Dermal Therapy (Barbados) Inc. Topical analgesic composition

Also Published As

Publication number Publication date
WO1999013885A1 (fr) 1999-03-25
NZ503418A (en) 2001-02-23
JP2001516721A (ja) 2001-10-02
EP1019063A1 (fr) 2000-07-19
AU737867B2 (en) 2001-09-06
IL135091A0 (en) 2001-05-20
EP1019063A4 (fr) 2003-09-03
NO20001341D0 (no) 2000-03-15
NO20001341L (no) 2000-05-16
CA2304119A1 (fr) 1999-03-25
AU9389098A (en) 1999-04-05
BR9812321A (pt) 2000-09-05

Similar Documents

Publication Publication Date Title
Loeb et al. Activity of a new antimalarial agent, chloroquine (SN 7618): Statement approved by the Board for coordination of malarial studies
CA2078221C (fr) Compositions pharmaceutiques comprenant de la taurolidine et/ou du taurultam
US4690918A (en) Use of trichostatin compounds for treating tumor cells
Pratt Response of childhood rhabdomyosarcoma to combination chemotherapy
Tawil et al. Acetazolamide‐induced nephrolithiasis: implications for treatment of neuromuscular disorders
CA2431278A1 (fr) Methodes de traitement des troubles anxieux
CN1128615C (zh) 预防和治疗癌性疾病的药物组合物及其制备方法
Westenfelder et al. Vancomycin-streptomycin synergism in enterococcal endocarditis
EA001929B1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
CN105492426B (zh) N‑(4‑羟基‑4‑甲基‑环己基)‑4‑苯基‑苯磺酰胺和n‑(4‑羟基‑4‑甲基‑环己基)‑4‑(2‑吡啶基)苯磺酰胺和其治疗性用途
CN1279612A (zh) 免疫应答的调制
DE10300222A1 (de) Verwendung von Wirksubstanzen zur Prophylaxe und/oder Therapie von Viruserkrankungen
CN100569237C (zh) 一种抗腺病毒的药物及用途
RU2054288C1 (ru) Способ профилактики и лечения острых желудочно-кишечных болезней новорожденных телят
KR20040060958A (ko) 인터페론-γ 생산 촉진제
US3433875A (en) The improvement of mental performance with potassium n-acetyl dl aminosuccinate
RU2703723C1 (ru) Способ коррекции тревожно-депрессивных расстройств у больных с системными заболеваниями соединительной ткани
CN1034133A (zh) 聚集在皮肤内的外用抗病毒药及其制备方法
AU619027B2 (en) Method for suppressing immune responses by administering imexon
JPH04202126A (ja) インターロイキン―１産生抑制剤
EP0540945A1 (fr) Composés bioactifs et préparations pharmaceutiques
RU2026072C1 (ru) Средство для стимуляции репаративных процессов
RU2166314C2 (ru) Лечебно-профилактическое средство "гексикон", обладающее антибактериальным и антисептическим действием
Kusum et al. A REVIEW ON SUSTAINED RELEASE TABLETS
Talkov et al. The failure of cobra venom to relieve pain in rheumatoid arthritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1031837

Country of ref document: HK